Sodium cromoglicate oral - Emisphere

Drug Profile

Sodium cromoglicate oral - Emisphere

Alternative Names: Cromoglicic acid oral - Emisphere; Cromoglycic acid oral - Emisphere; Cromolyn oral - Emisphere; Cromolyn sodium oral - Emisphere; Oral cromoglicic acid; Oral cromoglycic acid; Oral cromolyn; Oral cromolyn sodium; Oral sodium cromoglicate; Sodium cromoglycate oral - Emisphere

Latest Information Update: 09 May 2011

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Emisphere Technologies
  • Class Antiallergics; Antiasthmatics; Antitussives; Benzopyrans; Chromones; Nootropics; Small molecules
  • Mechanism of Action Mast cell stabilisers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Asthma; Hypersensitivity

Most Recent Events

  • 08 Aug 2005 Phase-I clinical trials in Allergy in USA (PO)
  • 08 Aug 2005 Phase-I clinical trials in Asthma in USA (PO)
  • 29 Jul 2002 Phase-II clinical trials in Allergy in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top